Geode Capital Management, LLC Better Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.14 - $0.39 $8,672 - $24,157	61,943 Added 57.96%	168,821 $33,000
Q3 2023 Nov 13, 2023	SELL	$0.34 - $1.23 $5,047 - $18,260	-14,846 Reduced 12.2%	106,878 $39,000
Q2 2023 Aug 11, 2023	BUY	$0.69 - $1.46 $44,584 - $94,337	64,615 Added 113.14%	121,724 $131,000
Q4 2022 Feb 13, 2023	SELL	$1.1 - $1.74 $148 - $234	-135 Reduced 0.24%	57,109 $63,000
Q3 2022 Nov 14, 2022	BUY	$1.53 - $2.77 $29,529 - $53,461	19,300 Added 50.86%	57,244 $100,000
Q2 2022 Aug 12, 2022	BUY	$0.91 - $2.34 $2,818 - $7,246	3,097 Added 8.89%	37,944 $59,000
Q1 2022 May 13, 2022	BUY	$1.98 - $5.01 $68,997 - $174,583	34,847 New	34,847 $68,000

Ticker BTTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,743,000
Description
Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional ...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.